fax: (966)-1-8011111 # 18880
Liver Failure/Cirrhosis/Portal Hypertension
Article first published online: 4 DEC 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 6, pages 2305–2315, December 2012
How to Cite
Arabi, Y. M., Dara, S. I., Memish, Z., Al Abdulkareem, A., Tamim, H. M., Al-Shirawi, N., Parrillo, J. E., Dodek, P., Lapinsky, S., Feinstein, D., Wood, G., Dial, S., Zanotti, S., Kumar, A. and for the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group (2012), Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology, 56: 2305–2315. doi: 10.1002/hep.25931
Potential conflict of interest: Anand Kumar received unrestricted research grants from Eli-Lilly, Pfizer, Bayer, Astellas, Merck, the Manitoba Health Research Council, the Health Sciences Centre (Winnipeg) Foundation, the Innovations and Opportunities Foundation (Winnipeg), and the Deacon Foundation (Winnipeg).
Additional and associate members of the Cooperative Antimicrobial Therapy of Septic Shock Database Research Group are listed in the Appendix.
- Issue published online: 4 DEC 2012
- Article first published online: 4 DEC 2012
- Accepted manuscript online: 30 JUN 2012 02:02AM EST
- Manuscript Accepted: 12 JUN 2012
- Manuscript Received: 25 OCT 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.